The RNA Component of Human Telomerase
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Eukaryotic chromosomes are capped with repetitive telomere sequences that protect the ends from damage and rearrangements. Telomere repeats are synthesized by telomerase, a ribonucleic acid (RNA)-protein complex. Here, the cloning of the RNA component of human telomerase, termed hTR, is described. The template region of hTR encompasses 11 nucleotides (5′-CUAACCCUAAC) complementary to the human telomere sequence (TTAGGG) n . Germline tissues and tumor cell lines expressed more hTR than normal somatic cells and tissues, which have no detectable telomerase activity. Human cell lines that expressed hTR mutated in the template region generated the predicted mutant telomerase activity. HeLa cells transfected with an antisense hTR lost telomeric DNA and began to die after 23 to 26 doublings. Thus, human telomerase is a critical enzyme for the long-term proliferation of immortal tumor cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Key components of telomerase are telomerase reverse transcriptase (TERT) (88) and telomerase RNA (89).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [89]
In the citing paper
“expression of antisense RNA complementary to the human telomerase RNA component (hTR) caused decreased proliferation of HeLa cells after 23 to 26 doublings (24).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [24]
In the citing paper
“The shortening of telomeres occurs with each cell division, ultimately causing cells to reach their Hayflick limit, whereby growth stops after approximately 60 times population doubling [2,3,4,5].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“When telomeres become too short and cannot function naturally, cellular senescence in the M1 phase (a cellular growth arrest, also called the M1 stage) occurs [5,6,7].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“In human cells, the enzyme comprises a high molecular weight complex with a template-containing RNA subunit (Feng et al., 1995) and protein components including the catalytic subunit human telomerase reverse transcriptase, hTERT (Harrington et al., 1997;Meyerson et al., 1997;Nakamura et al., 1997).”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Feng et al., 1995
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Self-citationTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Self-citationTight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Self-citationTelomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Self-citationCounter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Self-citationOlovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643
Self-citation
Research works printed but not linked: 7
- AUTEXIER, C, FUNCTIONAL RECONSTITUTION OF WILD-TYPE AND MUTANT TETRAHYMENA TELOMERASE, GENES & DEVELOPMENT 8: 563 (1994). · DOI
- AVILION A.A. THESIS STATE U NEW Y (1995).
- Broccoli, D., Proceedings of the National Academy of Sciences of the United States of America 92: 9082 (1995).
- CHADENEAU, C, ONCOGENE 11: 841 (1995).
- Hernandez, N., Transcriptional Regulation: 281 (1992).
- Muller, H. J., Collecting Net 13: 181 (1938).
- WATSON, J. D., NATURE-NEW BIOLOGY 239: 197 (1972).
Cited by
Items 901–1,000 of 1,004
Telomerase activity in oral and maxillofacial tumors
Liao, J. (2000) · Oral Oncology · doi:10.1016/s1368-8375(00)00013-0 · Cited by 39
“Telomerase is a ribonucleoprotein DNA polymerase containing an RNA component that directs the synthesis of telomeric DNA repeats and compensates for the loss of telomeres during cell division [4,5].”
BackgroundTentori, L., Balduzzi, A., Portarena, I., Levati, L., Vernole, P., Gold, B. I., Bonmassar, E., & Graziani, G. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400863 · Cited by 45
Azouz, A., Wu, Y.-L., Hillion, J., Tárkányi, I., Karniguian, A., Aradi, J., Lanotte, M., Chen, G.-Q., Chehna, M. F., & Ségal-Bendirdjian, E. (2010) · Leukemia · doi:10.1038/leu.2009.283 · Cited by 42
Telomerase inhibition and the future management of head-and-neck cancer
McCaul, J. A., Gordon, K., Clark, L., & Parkinson, E. K. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00729-5 · Cited by 44
Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide
Sato, N., Mizumoto, K., Kusumoto, M., Nishio, S., Maehara, N., Urashima, T., Ogawa, T., & Tanaka, M. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1117 · Cited by 42
“Three major components of huma telomerase have been identified: human telomerase RNA, hT (Feng et al, 1995); telomerase-associated protein, T (Harrington et al, 1997; Nakayama et al, 1997); and human merase reverse transcriptase, hTERT (Meyerson et al, 1 sisowlrase othage Received 15 November 1999…”
BackgroundOhyashiki, J. H., Hisatomi, H., Nagao, K., Honda, S., Takaku, T., Zhang, Y., Sashida, G., & Ohyashiki, K. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602546 · Cited by 41
“Another essential element to control telomerase activity is the RNA component of telomerase (hTR: human telomerase template RNA) (Feng et al, 1995; Weinrich et al, 1997).”
BackgroundShin, J., Chung, J., Kim, H. S., Kim, Y., Hur, Y., Rhim, J., Chung, H., Park, S. Y., Park, J., & Yang, H.-K. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.16.s2.33.x · Cited by 41
Telomerase confers resistance to caspase-mediated apoptosis
Bermudez, Y., Erasso, D. M., Johnson, N. C., Matte, M. Y. A.-D., Lowell, N. E., & Kruk, P. A. (2006) · Clinical Interventions in Aging · doi:10.2147/ciia.2006.1.2.155 · Cited by 41
Cloning and Characterization of Leishmania donovani Telomeres
Chiurillo, M. Á., Beck, A. E., deVos, T., Myler, P. J., Stuart, K., & Ramı́rez, J. L. (2000) · Experimental Parasitology · doi:10.1006/expr.2000.4499 · Cited by 39
Telomerase activity and in situ telomerase RNA expression in oral carcinogenesis
Chang, L., Lin, S., Chang, C.-S., Wong, Y., Hu, Y., & Chang, K. (1999) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1999.tb02109.x · Cited by 42
Miyoshi, T., Hirohata, S., Ogawa, H., Doi, M., Obika, M., Yonezawa, T., Sado, Y., Kusachi, S., Kyo, S., Kondo, S., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5565fje · Cited by 40
“The enzyme is composed of a functional or template RNA component (hTER) and a telomerase catalytic protein subunit or human telomerase reverse transcriptase (hTERT) (22, 23 ).”
BackgroundSynthesis of 6-formyl-pyridine-2-carboxylate derivatives and their telomerase inhibitory activities
Jew, S., Park, B., Lim, D., Kim, M. G., Chung, I. K., Kim, J. H., Hong, C. I., Kim, J., Park, H.-J., Lee, J.-H., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)01041-7 · Cited by 44
Mccormick-Graham, M., Haynes, W. J., & Romero, D. P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.11.3233 · Cited by 40
“…with misincorporation by telomerase Graham and Romero, 1995, 1996), yeast (Singer andMonica McCormick-Graham, Gottschling, 1994; McEachern and Blackburn, 1995),W.John Haynes1 and Daniel P.Romero2 mouse (Blasco et al., 1995) and human (Feng et al., Department of Pharmacology, Medical School,…”
BackgroundMethodInfluentialExpression of human telomerase subunit genes in primary lung cancer and its clinical significance
Arinaga, M., Shimizu, S., Gotoh, K., Haruki, N., Takahashi, T., Takahashi, T., & Mitsudomi, T. (2000) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(00)01454-5 · Cited by 41
Mechanism for the Reduction of Telomerase Expression during Muscle Cell Differentiation
Nozawa, K., Maehara, K., & Isobe, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011181200 · Cited by 42
Expression of telomerase component genes in hepatocellular carcinomas
Takahashi, S., Kitamoto, M., Takaishi, H., Aikata, H., Kawakami, Y., Nakanishi, T., Shimamoto, F., Tahara, E., Tahara, H., Ide, T., et al. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00284-1 · Cited by 45
“In humans, three such subunits have been identi®ed and extensively analysed, human telomerase RNA component (hTERC), encoding the RNA component of telomerase [8,9], telomerase-associated protein 1 (TEP1), encoding a telomerase-associated protein of unknown function [10,11] and human telomerase reverse transcriptase (h…”
BackgroundKruk, P. A., Godwin, A. K., Hamilton, T. C., & Auersperg, N. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5348 · Cited by 44
Toward Identifying a Cellular Determinant of Telomerase Repression
Shay, J. W. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.1.4 · Cited by 39
Detection of telomerase on upconversion nanoparticle modified cellulose paper
Wang, F., Li, W., Wang, J., Ren, J., & Qu, X. (2015) · Chemical Communications · doi:10.1039/c5cc03902a · Cited by 38
Gansner, J. M., & Rosas, I. O. (2013) · Translational research · doi:10.1016/j.trsl.2013.04.001 · Cited by 42
Lagadari, M., Zgajnar, N. R., Gallo, L. I., & Galigniana, M. D. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.05.002 · Cited by 38
“Both subunits are essential for restoring telomerase activity in vitro and the introduction of these genes into normal cells extend the life span of these otherwise mortal cells (Feng et al., 1995; Meyerson et al., 1997).”
BackgroundRetractedSnoRNAs and the emerging class of sdRNAs: Multifaceted players in oncogenesis
Abel, Y., & Rederstorff, M. (2019) · Biochimie · doi:10.1016/j.biochi.2019.05.006 · Cited by 38
Telomere length regulation during cloning, embryogenesis and ageing
Schaetzlein, S., & Rudolph, K. L. (2004) · Reproduction Fertility and Development · doi:10.1071/rd04112 · Cited by 43
“The RNA subunit provides the template for telomere synthesis and the reverse transcriptase is the catalytic subunit of the enzyme (Greider and Blackburn 1985; Morin 1989; Feng et al. 1995; Meyerson et al. 1997; Nugent and Lundblad 1998).”
BackgroundGramatges, M. M., Qi, X., Sasa, G., Chen, J. J. ‐., & Bertuch, A. A. (2013) · Blood · doi:10.1182/blood-2012-08-447755 · Cited by 43
“The catalytic protein subunit of telomerase, hTERT, is encoded by telomerase reverse transcriptase (TERT), and the integral RNA subunit, hTR, is encoded by telomerase RNA component (TERC).(2,3) At present, 34 disease-associated sequence variants have been described within TERT, the majority of which are missense chang…”
BackgroundMoon, D., Kim, M.-O., Heo, M., Lee, J.-D., Choi, Y. H., & Kim, G. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-2002-7 · Cited by 39
Parkinson, E. K., Newbold, R. F., & Keith, W. N. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00063-4 · Cited by 39
Cerezo, A., Stark, H., Moshir, S., & Boukamp, P. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12304.x · Cited by 41
Telomere shortening induces aging-associated phenotypes in hiPSC-derived neurons and astrocytes
Harley, J., Santosa, M. M., Ng, C. Y., Grinchuk, O. V., Hor, J., Liang, Y., Lim, V. J. W., Tee, W., Ong, D. S. T., & Ng, S. (2023) · Biogerontology · doi:10.1007/s10522-023-10076-5 · Cited by 38
“It consists of two main components; the catalytic subunit telomerase reverse transcriptase (TERT) and a telomerase RNA component (TERC) (Shay and Wright 2019; Nakamura et al. 1997; Feng et al. 1995).”
BackgroundLi, C., Wu, M., Liang, Y., & Wu, X. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i11.2395 · Cited by 41
“hTR containing the template for reverse transcription[ 1 ], and telomerase associated proteins.”
MethodGene Expression Profile of the Hippocampus of Rats Subjected to Chronic Immobilization Stress
Li, X., Chen, J., Yue, G.-X., Liu, Y., Zhao, X., Guo, X.-L., Liu, Q., Jiang, Y.-M., & Bai, M.-H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057621 · Cited by 41
hTERT: Another brick in the wall of cancer cells
Lamy, E., Goetz, V., Erlacher, M., Herz, C., & Mersch‐Sundermann, V. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.12.005 · Cited by 38
The Pleiotropy of Telomerase against Cell Death
Sung, Y. H., Choi, Y. S., Cheong, C., & Lee, H. (2005) · Molecules and Cells · doi:10.1016/s1016-8478(23)13173-6 · Cited by 42
“When telomerase activity is suppressed using antisense TERC, HeLa cells begin to die after 23 to 26 doublings and malignant glioma U251-MG cells undergo apoptosis after 30 doublings, possibly due to telomere erosion (Feng et al., 1995; Kondo et al., 1998).”
Insights from human genetic studies of lung and organ fibrosis
Garcia, C. K. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93556 · Cited by 40
“Telomerase, composed of a catalytic protein component (encoded in the human by the TERT gene) and an RNA template (TERC), solves the end replication problem by directly adding telomeric DNA repeats to the ends of the chromosomes (10, 11).”
BackgroundCabuy, E., & Ridder, L. D. (2001) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280100466 · Cited by 46
“Telomerase is a ribonucleoprotein polymerase composed of an integral RNA component (hTR) [14] and several protein components, including the reverse transcriptase subunit hTERT [18, 32].”
BackgroundBermudez, Y., Yang, H., Cheng, J. Q., & Kruk, P. A. (2008) · Growth Factors · doi:10.1080/08977190802001389 · Cited by 37
“While both protein catalytic hTERT and hTR subunits have been identified and cloned, the protein catalytic subunit is the limiting determinant of telomerase activity (Feng et al. 1995; Meyerson et al. 1997; Weinrich et al. 1997; Counter et al. 1998).”
BackgroundMedical genetics and epigenetics of telomerase
Koziel, J. E., Fox, M. J., Steding, C. E., Sprouse, A. A., & Herbert, B.-S. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01276.x · Cited by 36
“In human beings, the core enzyme comprises the protein hTERT, which contains a reverse transcriptase domain capable of catalysing the addition of a six nucleotide repeat onto the ends of telomeres [9], and an RNA component, termed hTR or hTERC (TElomerase RNA Component), which contains a template region that is comple…”
BackgroundThe correlation of TERT expression with c-myc expression in cervical cancer
Sagawa, Y., Nishi, H., Isaka, K., Fujito, A., & Takayama, M. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00501-8 · Cited by 37
Nylander, K., Bourdon, J.-C., Bray, S. E., Gibbs, N. K., Kay, R., Hart, I., & Hall, P. A. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200001)190:1<39::aid-path492>3.0.co;2-v · Cited by 98
Telomerase as a new target for the treatment of hormone-refractory prostate cancer
Biroccio, A., & Leonetti, C. (2004) · Endocrine Related Cancer · doi:10.1677/erc.1.00764 · Cited by 40
“The telomerase holoenzyme consists of the catalytic subunit reverse transcriptase protein hTERT (Nakamura et al. 1997), the telomerase RNA template subunit, hTR (Feng et al. 1995) and other associated proteins (Harrington et al. 1997).”
BackgroundZaffaroni, N., Villa, R., Pastorino, U., Cirincione, R., Incarbone, M., Alloisio, M., Curto, M., Pilotti, S., & Daidone, M. G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1293 · Cited by 41
Cyclin D3 expression in normal, reactive and neoplastic tissues
Doglioni, C., Chiarelli, C., Macrí, E., Dei Tos, A. P., Meggiolaro, E., Dalla Palma, P., & Barbareschi, M. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199806)185:2<159::aid-path73>3.0.co;2-0 · Cited by 63
Telomerase and Telomeres: From Basic Biology to Cancer Treatment
Helder, M. N., Wisman, G. B. A., & van der Zee, A. G. J. (2002) · Cancer Investigation · doi:10.1081/cnv-120000370 · Cited by 41
“Antisense RNA Approach When AS hTR expression constructs were introduced in HeLa (17) or human glioma cells (86), most of the cultures lost telomeric DNA and went into crisis, whereas none of the controls (vector alone) did.”
BackgroundInfluentialOverexpression of human telomerase RNA is an early event in oesophageal carcinogenesis
Hiyama, T., Yokozaki, H., Kitadai, Y., Haruma, K., Yasui, W., Kajiyama, G., & Tahara, E. (1999) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050372 · Cited by 39
“The RNA component of human telomerase (hTR) was recently cloned [ 1 ].”
Kallassy, M., Martel, N., Damour, O., Yamasaki, H., & Nakazawa, H. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199801)21:1<26::aid-mc5>3.3.co;2-p · Cited by 37
Expression of Tankyrase 1 in Gastric Cancer and Its Correlation with Telomerase Activity
Gao, J., Zhang, J., Long, Y., Tian, Y., & Lu, X. (2011) · Pathology & Oncology Research · doi:10.1007/s12253-011-9369-8 · Cited by 36
“The human telomerase consists of two essential components: human telomerase RNA component (hTERC), which serves as a template for the synthesis of telomere repeat sequence and human telomerase reverse transcriptase (hTERT), which is the catalytic component of the enzyme [ 7 , 8]. Telomerase activity is repressed in so…”
BackgroundGuruprasad, K. P., Dash, S., Shivakumar, M. B., Shetty, P. R., Raghu, K. S., Shamprasad, B. R., Udupi, V., Acharya, R. V., Vidya, P. B., Nayak, J., et al. (2017) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2017.01.007 · Cited by 38
“These cells were used as they show very high telomerase activity and the telomere length remains constant up to 23e26 cell doublings [23,24].”
Telomerase activity and telomere on stem progeny senescence
Brazvan, B., Kalan, A. E., Velaei, K., Mehdipour, A., Serej, Z. A., Ebrahımı, A., Ghorbani, M., Cheraghi, O., & Charoudeh, H. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.073 · Cited by 40
Ovarian Telomerase and Female Fertility
Toupance, S., Fattet, A.-J., Thornton, S. N., Bénétos, A., Guéant, J., & Koscinski, I. (2021) · Biomedicines · doi:10.3390/biomedicines9070842 · Cited by 38
“TERC is constitutively expressed in cells, whereas TERT is detected only in telomerase-positive cells [11,12].”
BackgroundSachsinger, J., González‐Suárez, E., Samper, E., Heicappell, R., Müller, M., & Blasco, M. A. (2001) · PubMed · Cited by 45
Telomerase and its extracurricular activities
Jaiswal, R. K., Kumar, P., & Yadava, P. K. (2013) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-013-0105-0 · Cited by 38
Natarajan, S., Chen, Z., Wancewicz, E. V., Monia, B. P., & Corey, D. R. (2004) · Oligonucleotides · doi:10.1089/oli.2004.14.263 · Cited by 37
“Telomerase consists of two components, a protein reverse transcriptase (hTERT) (Meyerson et al., 1997; Nakamura et al., 1997) and an RNA (hTR) (Feng et al., 1995).”
Shah, B. A., Kaur, R., Gupta, P., Kumar, A., Sethi, V. K., Andotra, S. S., Singh, J., Saxena, A. K., & Taneja, S. C. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.089 · Cited by 36
Leon-Blanco, M. M., Guerrero, J. M., Reiter, R. J., & Pozo, D. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.05.003 · Cited by 36
Branca, M., Giorgi, C., Ciotti, M., Santini, D., Bonito, L. D., Costa, S. P. S., Benedetto, A., Bonifacio, D., Bonito, P. D., Paba, P., et al. (2006) · Diagnostic Cytopathology · doi:10.1002/dc.20554 · Cited by 36
Hoffmann, J., & Spyridopoulos, I. (2011) · Future Cardiology · doi:10.2217/fca.11.55 · Cited by 37
“As a template, telomerase uses an associated RNA component called TERC (3 ́ CAAUCCCAAUC 5 ́ in humans) (see Figure 2) [36].”
BackgroundEstablishment of Immortalized Human Oral Keratinocytes by Gene Transfer of a Telomerase Component
Fujimoto, R., Kamata, N., YOKOYAMA, K., Taki, M., Tomonari, M., TSUTSUMI, S., Yamanouchi, K., & Nagayama, M. (2002) · Journal of Japanese Society for Oral Mucous Membrane · doi:10.6014/jjomm1995.8.1 · Cited by 36
Functional and mechanistic analysis of telomerase: An antitumor drug target
Chen, Y., & Zhang, Y. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.017 · Cited by 39
Human Telomerase RNA Template Sequence Is a Determinant of Telomere Repeat Extension Rate
Drosopoulos, W. C., DiRenzo, R., & Prasad, V. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506319200 · Cited by 41
Cell proliferation, carcinogenesis and diverse mechanisms of telomerase regulation
Krupp, G., Klapper, W., & Parwaresch, R. M. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000708 · Cited by 41
Telomere length and telomerase activity in canine mammary gland tumors
Yazawa, M., Okuda, M., Setoguchi, A., Iwabuchi, S., Nishimura, R., Sasaki, N., Masuda, K., Ohno, K., & Tsujimoto, H. (2001) · American Journal of Veterinary Research · doi:10.2460/ajvr.2001.62.1539 · Cited by 41
Telomere instability in a human cancer cell line
Sprung, C. N., Afshar, G., Chavez, E. A., Lansdorp, P. M., Sabatier, L., & Murnane, J. P. (1999) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(99)00115-3 · Cited by 38
Ogoshi, M., Le, T., Shay, J. W., & Taylor, R. S. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00180.x · Cited by 36
Greene, E. C., & Shippen, D. E. (1998) · Genes & Development · doi:10.1101/gad.12.18.2921 · Cited by 41
“Telomerase RNAs identified in yeast and mammals are significantly larger than their ciliate counterparts (Singer and Gottschling 1994; Blasco et al. 1995; Feng et al. 1995), and currently, no phylogenetic or structural data are available for these molecules.”
BackgroundCancer stem cells and telomerase as potential biomarkers in veterinary oncology
Pang, L. Y., & Argyle, D. J. (2010) · The Veterinary Journal · doi:10.1016/j.tvjl.2010.04.008 · Cited by 40
Telomere protein complexes and interactions with telomerase in telomere maintenance
Pinto, A. R., Li, H., Nicholls, C., & Liu, J. (2010) · Frontiers in bioscience · doi:10.2741/3683 · Cited by 40
“Although TER and dyskerin are expressed ubiquitously in normal and cancer cells (60-65), TERT is specifically present in highly proliferative or cancerous cells (65-67) and subject to positive and negative regulation by opposing cellular factors (reviewed in (68)).”
BackgroundDiverse regulatory manners of human telomerase reverse transcriptase
Jie, M., Chang, X., Zeng, S., Liu, C., Liao, G., Wu, Y., Liu, C., Hu, C.-J., Yang, S., & Li, X. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0372-0 · Cited by 38
TERT Extra-Telomeric Roles: Antioxidant Activity and Mitochondrial Protection
Marinaccio, J., Micheli, E., Udroiu, I., Nottia, M. D., Carrozzo, R., Baranzini, N., Grimaldi, A., Leone, S., Moreno, S., Muzzi, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054450 · Cited by 37
“In order to counteract telomere shortening, in humans, the main mechanism of telomere length maintenance involves the enzyme telomerase, a ribonucleoprotein complex consisting of two subunits: a functional catalytic protein called telomerase reverse transcriptase (TERT) and an RNA component (TERC), which works as a te…”
BackgroundTelomerase, immortality and cancer
Krupp, G., Bonatz, G., & Parwaresch, R. M. (2000) · Biotechnology annual review · doi:10.1016/s1387-2656(00)06020-8 · Cited by 39
A click chemistry approach to C3 symmetric, G-quadruplex stabilising ligands
Moses, J. E., Ritson, D. J., Zhang, F., Lombardo, C. M., Haider, S. M., Oldham, N. J., & Neidle, S. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c005055e · Cited by 38
Yoo, J., Park, S. Y., Kang, S. J., Kim, B. K., Shim, S. I., & Kang, C. S. (2003) · Modern Pathology · doi:10.1097/01.mp.0000077517.44687.b6 · Cited by 39
“Human telomerase RNA (hTR) is one of the major subunits of telomerase, encompassing 11 nucleotides (5'-CUAACCCUAAC) complementary to the human telomeric repeats (21).”
BackgroundRegulation of telomerase expression in human lymphocytes
Weng, N. (2002) · Springer Seminars in Immunopathology · doi:10.1007/s00281-001-0093-4 · Cited by 39
Sporadic colorectal adenocarcinomas with high‐frequency microsatellite instability
Gafà, R., Maestri, I., Matteuzzi, M., Santini, A., Ferretti, S., Cavazzini, L., & Lanza, G. (2000) · Cancer · doi:10.1002/1097-0142(20001115)89:10<2025::aid-cncr1>3.3.co;2-j · Cited by 216
Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules
Janson, C. G., & During, M. J. (2006) · Springer eBooks · doi:10.1007/0-387-32956-0 · Cited by 41
The role of telomerase activity in hepatocellular carcinoma
Shimada, M., Hasegawa, H., Gion, T., Utsunomiya, T., Shirabe, K., Takenaka, K., Otsuka, T., Maehara, Y., & Sugimachi, K. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00914-4 · Cited by 35
Expression of Telomerase RNA, Telomerase Activity, and Telomere Length in Human Gliomas
Morii, K., Tanaka, R., Onda, K., Tsumanuma, I., & Yoshimura, J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7562 · Cited by 39
McMurray, H. R., & McCance, D. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5698-5706.2004 · Cited by 40
“The TERT subunit of the enzyme is the limiting factor in telomerase activity, as the TERC molecule is ubiquitously expressed (11, 25), and overexpression of the TERT gene alone is sufficient to engender high levels of telomerase activity in all cell types examined (10, 55).”
BackgroundMacnamara, B., Wang, W., Chen, Z., Hou, M., Mazur, J., Gruber, A., & Porwit‐MacDonald, A. (2001) · PubMed · Cited by 39
Telomerase in endocrine and endocrine-dependent tumors
Orlando, C., & Gelmini, S. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00101-7 · Cited by 35
TRF1 is a critical trans-acting factor required for de novo telomere formation in human cells
Okabe, J., Eguchi, A., Masago, A., Hayakawa, T., & Nakanishi, M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.18.2639 · Cited by 37
“Secondly, forced expression of telomerase by transgenesis can extend the lifespan of various somatic cells (15), whereas the inhibition of telomerase activity by antisense RNA forces immortal HeLa cells into crisis (16).”
BackgroundZaffaroni, N., Porta, C. D., Villa, R., Botti, C., Buglioni, S., Mottolese, M., & Daidone, M. G. (2002) · The Journal of Pathology · doi:10.1002/path.1178 · Cited by 40
“hTR and hTEP1 are widely expressed in cells whether or not they have telomerase activity [4].”
BackgroundLi, T., Zou, L., Zhang, J., Li, G., & Ling, L. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.03.039 · Cited by 34
Yue, X., Qiao, Y., Gu, D., Wu, Z., Zhao, W., Li, X., Yin, Y., Zhao, W. G., Kong, D., Xi, R., et al. (2020) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.127943 · Cited by 34
Composition and Function of Telomerase—A Polymerase Associated with the Origin of Eukaryotes
Schrumpfová, P. P., & Fajkus, J. (2020) · Biomolecules · doi:10.3390/biom10101425 · Cited by 38
“RNA Polymerase RNA Pol II [66] RNA Pol III [19,20]”
InfluentialLong non-coding RNAs at work on telomeres: Functions and implications in cancer therapy
Gala, K., & Khattar, E. (2021) · Cancer Letters · doi:10.1016/j.canlet.2020.12.036 · Cited by 37
Nakashima, A., Murakami, Y., Uemura, K., Hayashidani, Y., Sudo, T., Hashimoto, Y., Ohge, H., Oda, M., Sueda, T., & Hiyama, E. (2009) · Pancreas · doi:10.1097/mpa.0b013e3181a16d28 · Cited by 35
Zhao, Y., Zhou, Q., Yun, X., Lai, X., & Huang, H. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00767.x · Cited by 36
Processive Utilization of the Human Telomerase Template
Rivera, M. A., & Blackburn, E. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407768200 · Cited by 34
Riou, L., Bastos, H., Lassalle, B., Coureuil, M., Testart, J., Boussin, F. D., Allemand, I., & Fouchet, P. (2005) · Endocrinology · doi:10.1210/en.2005-0502 · Cited by 36
Inhibition of Telomerase Activity by Preventing Proper Assemblage
Keppler, B. R., & Jarstfer, M. B. (2003) · Biochemistry · doi:10.1021/bi035583e · Cited by 39
Telomere control of replicative lifespan
Morin, G. B. (1997) · Experimental Gerontology · doi:10.1016/s0531-5565(96)00164-7 · Cited by 39
Chen, H., Wang, W., Mo, Y., Ma, Y., Ouyang, N., Li, R., Mai, M.-Q., He, Y., Bodombossou-Djobo, M. M. A., & Yang, D. (2011) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-011-9600-2 · Cited by 36
Role of Pin2/TRF1 in telomere maintenance and cell cycle control
Zhou, X. Z., Perrem, K., & Lu, K. P. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10496 · Cited by 37
“In contrast, suppressing telomerase function causes telomere shortening, and often forces transformed cells to enter crisis [Feng et al., 1995; Hahn et al., 1999b; Herbert et al., 1999; Zhang et al., 1999].”
BackgroundInfluentialTelomeres and DNA damage checkpoints
Viscardi, V., Clerici, M., Cartagena‐Lirola, H., & Longhese, M. P. (2004) · Biochimie · doi:10.1016/j.biochi.2004.10.022 · Cited by 38
Telomerase: A Target for Anticancer Therapy
Lichtsteiner, S., LEBKOWSKI, J. S., & Vasserot, A. P. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09395.x · Cited by 36
Rohde, V., Sattler, H., Bund, T., Bonkhoff, H., Fixemer, T., Bachmann, C., Lensch, R., Unteregger, G., Stoeckle, M. Y., & Wullich, B. (2000) · PubMed · Cited by 41
Harland, J. L., Chang, Y.-T., Moser, B. A., & Nakamura, T. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004708 · Cited by 34
“Since introduction of tpz1-W498R,I501R or tpz1-[1–485] caused telomere extensions comparable to poz1D (Figure 6A), we expected that loss of Tpz1-Poz1 interaction would cause increases”
InfluentialDeeb, D., Gao, X., Liu, Y., Kim, S.-H., Pindolia, K. R., Arbab, A. S., & Gautam, S. C. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.024 · Cited by 34
“telomerase reverse transcriptase (hTERT), telomerase RNA (hTR or TERC) and telomerase associated protein-1 (TEP-1), hsp90 and p23 [4-6].”
BackgroundBeginning to Understand the End of the Chromosome
Cech, T. R. (2005) · Wiley eBooks · doi:10.1002/9783527620982.ch1 · Cited by 33
Synergy Between 3′Azido-3′deoxythymidine and Paclitaxel in Human Pharynx FaDu Cells
Johnston, J. S., Johnson, A. D., Gan, Y., Wientjes, M. G., & Au, J. L. ‐. (2003) · Pharmaceutical Research · doi:10.1023/a:1024431218327 · Cited by 36
“For example, telomerase inhibitors resulted in cytotoxicity in HeLa cells after 23 to 26 cell doublings (8).”
BackgroundBeisner, J., Dong, M., Taetz, S., Nafee, N. A., Griese, E., Schaefer, U. F., Lehr, C., Klotz, U. E., & Mürdter, T. E. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.07.010 · Cited by 37
“The ribonucleoprotein complex consists of two major components, the protein subunit human telomerase reverse trancriptase (hTERT) which has catalytic activity [5–7] and the human telomerase RNA component (hTR) which serves as a template for the synthesis of telomeric repeats to compensate telomere shortening [8].”
Background
Metadata
- Authors
- Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrews, Greider, C. W., & Villeponteau, B.
- Affiliations
- Geron (United States) (US)
- Cold Spring Harbor Laboratory (US)
- ORCID
- Venue
- Science
- Published
- 1995-09
- Volume
- 269
- Issue
- 5228
- Pages
- 1236-1241
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2026856852
- Cited by
- 2,227
- References
- 44
- Citations by year
- 2026: 10 · 2025: 23 · 2024: 20 · 2023: 36 · 2022: 35 · 2021: 33 · 2020: 44 · 2019: 52 · 2018: 55 · 2017: 44 · 2016: 74 · 2015: 54 · 2014: 47 · 2013: 62 · 2012: 61
- FWCI
- 54.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG09383)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- telomerase, hTR, telomeric repeats, antisense RNA, telomere shortening, HeLa cells
- MeSH terms
- Animals, Base Sequence, Cell Division, Cell Line, Cloning, Molecular, DNA Nucleotidylexotransferase, HeLa Cells, Humans, Molecular Sequence Data, RNA, Templates, Genetic, Transfection, Tumor Cells, Cultured, Polymerase Chain Reaction, Oligonucleotides, Antisense, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.